Gastroenterology
Partner With Us
Advertisement
Conexiant chevron_right Gastroenterology chevron_right SUC2C Grant Could Facilitate Development of Novel Therapies in Gastroesophageal Cancer
From the Journals

SUC2C Grant Could Facilitate Development of Novel Therapies in Gastroesophageal Cancer

A new collaboration between Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center to enhance gastroesophageal cancer care in patients who do not respond to standard treatment has received a 3-year grant from Stand Up To Cancer (SU2C).

Conexiant
Top Thought Leaders in Gastroenterology

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.